Verus Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-320
| Closed | -$228K | – | 432 |
|
|
2024
Q4 | $228K | Sell |
320
-20
| -6% | -$14.2K | 0.02% | 354 |
|
|
2024
Q3 | $357K | Buy |
340
+12
| +4% | +$12.6K | 0.03% | 259 |
|
|
2024
Q2 | $345K | Buy |
328
+2
| +0.6% | +$2.1K | 0.03% | 260 |
|
|
2024
Q1 | $314K | Buy |
326
+67
| +26% | +$64.5K | 0.03% | 249 |
|
|
2023
Q4 | $227K | Sell |
259
-26
| -9% | -$22.8K | 0.03% | 283 |
|
|
2023
Q3 | $235K | Sell |
285
-5
| -2% | -$4.12K | 0.03% | 254 |
|
|
2023
Q2 | $208K | Sell |
290
-30
| -9% | -$21.6K | 0.03% | 274 |
|
|
2023
Q1 | $263K | Buy |
+320
| New | +$263K | 0.04% | 232 |
|
|
2022
Q4 | – | Sell |
-375
| Closed | -$258K | – | 287 |
|
|
2022
Q3 | $258K | Sell |
375
-50
| -12% | -$34.4K | 0.05% | 221 |
|
|
2022
Q2 | $252K | Sell |
425
-135
| -24% | -$80K | 0.05% | 239 |
|
|
2022
Q1 | $364K | Buy |
+560
| New | +$364K | 0.06% | 226 |
|
|
2020
Q1 | $38K | Sell |
78
-162
| -68% | -$78.9K | 0.01% | 584 |
|
|
2019
Q4 | $90K | Buy |
+240
| New | +$90K | 0.03% | 409 |
|